Psychogenic movement disorders

Lancet Neurology

Volumn 5, Issue 8, 2006, Pages 695-700

  Hinson, Vanessa K ^a   Haren, W Blake ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE; CITALOPRAM; HALOPERIDOL; NEUROLEPTIC AGENT; PAROXETINE; SULPIRIDE; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; CLINICAL FEATURE; CLINICAL GLOBAL IMPRESSION SCALE; COGNITIVE THERAPY; COMORBIDITY; CONTRAST ENHANCEMENT; CONVERSION DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DRUG INDUCED DISEASE; ELECTROMYOGRAPHY; EMOTIONAL DISORDER; GAIT DISORDER; HUMAN; MOTOR DYSFUNCTION; MYOCLONUS; ONSET AGE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOGENIC MOVEMENT DISORDER; PSYCHOLOGIC ASSESSMENT; REMISSION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT PLANNING;

HUMANS; MOVEMENT DISORDERS; PSYCHOPHYSIOLOGIC DISORDERS; SOMATOFORM DISORDERS;

EID: 33745965330     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(06)70523-3     Document Type: Review

References (42)

1. Lipsitt D. Challenges of somatization: diagnostic, therapeutic and economic. Psychiatr Med 10 (1992) 1-12
2. Lempert T., Dieterich M., Huppert D., and Brandt T. Psychogenic disorders in neurology: frequency and clinical spectrum. Acta Neurol Scand 82 (1990) 335-340
3. Marsden C. Hysteria-a neurologist's view. Psychol Med 16 (1986) 277-288
4. Crimlisk H., Bhatia K., Cope C., David A., Marsden D., and Ron M. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ 316 (1998) 582-586
5. Factor S., Podskalny G., and Molho E. Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry 59 (1995) 406-412
6. Williams D., Ford B., and Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neurol 65 (1995) 233-257
7. Hinson V., Cubo E., Comella C., Leurgans S., and Goetz C. Rating scale for psychogenic movement disorders: scale development and clinimetric testing. Mov Disord 20 (2005) 1592-1597
8. Cubo E., Hinson V., Goetz C., et al. Transcultural comparison of psychogenic movement disorders. Mov Disord 20 (2005) 1343-1345
9. Ranawaya R., Riley D., and Lang A. Psychogenic dyskinesias in patients with organic movement disorders. Mov Disord 5 (1990) 127-133
10. Feinstein A., Stergiopoulus V., Fine J., and Lang A. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol 14 (2001) 169-176
11. American Psychiatric Association. Diagnostic and statistical manual for mental disorders. 4th edn. (1994), APA, Washington, DC, USA
12. Fahn S., and Williams P. Psychogenic dystonia. Adv Neurol 50 (1988) 431-455
13. Lang A., Koller W., and Fahn S. Psychogenic parkinsonism. Arch Neurol 52 (1995) 802-810
14. Kim Y., Pakiam A., and Lang A. Historical and clinical features of psychogenic tremor: a review of 70 cases. Can J Neurol Sci 26 (1999) 190-195
15. Deuschl G., Koester B., Luecking C., and Scheidt C. Diagnostic and pathophysiological aspects of psychogenic tremor. Mov Disord 13 (1998) 294-302
16. Morgan J., and Sethi K. Psychogenic parkinonism. In: Hallett M., Yudofsky S., Lang A., et al. (Eds). Psychogenic movement disorders (2006), Lippincott Williams & Wilkins, Philadelphia, USA 62-68
17. Schrag A. Psychogenic dystonia and reflex sympathetic dystrophy. In: Hallett M., Yudofsky S., Lang A., et al. (Eds). Psychogenic movement disorders (2006), Lippincott Williams & Wilkins, Philadelphia, USA 53-61
18. Lang A. Psychogenic dystonia: a review of 18 cases. Can J Neurol Sci 22 (1995) 136-143
19. Hayes M., Graham S., Heldorf P., deMoore G., and Morris J. A video review of the diagnosis of psychogenic gait: appendix and commentary. Mov Disord 14 (1999) 914-921
20. Bhatia K. Psychogenic gait disorders. Adv Neurol 87 (2001) 251-254
21. Thomas M., and Jankovic J. Psychogenic movement disorders. Diagnosis and management. CNS Drugs 18 (2004) 437-452
22. Tan E. Psychogenic tics: diagnostic value of the placebo test. J Child Neurol 19 (2004) 976-977
23. Monday K., and Jankovic J. Psychogenic myoclonus. Neurology 43 (1993) 349-352
24. Marjama J., Troster A., and Koller W. Psychogenic movement disorders. Neurol Clin 13 (1995) 283-297
25. Kirsch D., and Mink J. Psychogenic movement disorders in children. Pediatr Neurol 30 (2004) 1-6
26. de la Fuente-Fernández R., Schulzer M., and Stoessl A. Placebo mechanisms and reward circuitry: clues from Parkinson's disease. Biol Psychiatry 56 (2004) 67-71
27. Lang A. General overview of psychogenic movement disorders: epidemiology, diagnosis, and prognosis. In: Hallett M., Yudofsky S., Lang A., et al. (Eds). Psychogenic movement disorders (2006), Lippincott Williams & Wilkins, Philadelphia, USA 35-41
28. Factor S., Seibyl J., Innis R., and Marek. Psychogenic parkinonism: conformation of diagnosis with β-CIT SECT scans. Mov Disord 13 (1998) 860
29. 123 I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med 28 (2001) 266-272
30. 123I]β-CIT SPECT. Eur J Neurol 6 suppl (1999) 131
31. McAuley J., and Rothwell J. Identification of psychogenic, dystonic, and other organic tremors by a coherence entrainment test. Mov Disord 19 (2004) 253-267
32. Thompson P., Colebatch J., Brown P., Rothwell J., Obeso J., and Marsden C. Voluntary stimulus-sensitive jerks and jumps mimicking myoclonus or pathological startle syndromes. Mov Disord 7 (1992) 257-262
33. Jankovic J., Cloninger C., Fahn S., Hallett M., Lang A., and Williams D. Therapeutic approaches to psychogenic movement disorders. In: Hallett M., Yudofsky S., Lang A., et al. (Eds). Psychogenic movement disorders (2006), Lippincott Williams & Wilkins, Philadelphia, USA 323-328
34. Voon V., and Lang A. Antidepressant outcomes of psychogenic movement disorders. J Clin Psychiatry 66 (2005) 1529-1534
35. Hinson V., Weinstein S., Bernard B., Leurgans, and Goetz C. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord 12 (2006) 177-180
36. Menza M., Lauritano M., Allen L., et al. Treatment of somatization disorder with nefazodone: a prospective, open-label study. Ann Clin Psychiatry 13 (2001) 153-158
37. Rampello L., Raffaele R., Nicoletti G., LePira F., Malaguarnera M., and Drago F. Hysterical neurosis of the conversion type: therapeutic activity of neuroleptics with different hyperprolactinemic potency. Neuropsychobiology 33 (1996) 186-188
38. Moene F., Spinhoven P., Hoogduin K., and vanDyck R. A randomised controlled clinical trial on the additional effect of hypnosis in a comprehensive treatment programme for in-patients with conversion disorder of the motor type. Psychother Psychosom 71 (2002) 66-76
39. Sharpe M., Peveler R., and Mayou R. The psychological treatment of patients with functional somatic symptoms: a practical guide. J Psychosom Res 36 (1992) 515-529
40. Speckens A., van Hemert A., Spinhoven P., Hawton K., Bolk J., and Rooijmans H. Cognitive behavioral therapy for medically unexplained physical symptoms: a randomized controlled trial. BMJ 311 (1995) 1328-1332
41. Kroenke K., and Swindle R. Cognitive behavioral therapy for somatization and symptom syndromes: a critical review of controlled clinical trials. Psychother Psychosom 69 (2000) 205-215
42. Lazare A. Current concepts in psychiatry: conversion symptoms. N Engl J Med 305 (1981) 745-748